Moon S, Kim J, Lee Y, Cho H, Choi Y, Yoon J
Exp Mol Med. 2025; .
PMID: 40082672
DOI: 10.1038/s12276-025-01419-y.
Li L, Chen X, Liu H, Zhu Y, Xie M, Li Y
World J Gastroenterol. 2025; 31(9):98027.
PMID: 40061587
PMC: 11886039.
DOI: 10.3748/wjg.v31.i9.98027.
Hu G, Whitaker A, Zhang G, Karner C
Antioxidants (Basel). 2025; 14(2).
PMID: 40002383
PMC: 11851466.
DOI: 10.3390/antiox14020197.
Saadh M, Jasim N, Ahmed M, Ballal S, Kumar A, Atteri S
Clin Exp Med. 2025; 25(1):66.
PMID: 39998742
PMC: 11861128.
DOI: 10.1007/s10238-025-01600-7.
Sharan K, Brandt C, Yusuf M, Singh P, Halder N, Edwards M
iScience. 2025; 28(2):111802.
PMID: 39967874
PMC: 11834125.
DOI: 10.1016/j.isci.2025.111802.
The association of lipids and novel non-statin lipid-lowering drug target with osteoporosis: evidence from genetic correlations and Mendelian randomization.
Zheng Q, Lin R, Wang D, Chen R, Xu W
BMC Musculoskelet Disord. 2025; 26(1):107.
PMID: 39893413
PMC: 11787747.
DOI: 10.1186/s12891-024-08160-z.
Association between cardiovascular health and osteoporotic fractures: a national population-based study.
Ou J, Wang T, Lei R, Sun M, Ruan X, Wei J
Sci Rep. 2025; 15(1):3844.
PMID: 39885301
PMC: 11782481.
DOI: 10.1038/s41598-025-88020-5.
Degradation products of magnesium implant synergistically enhance bone regeneration: Unraveling the roles of hydrogen gas and alkaline environment.
An Y, Zhang H, Zhang S, Zhang Y, Zheng L, Chen X
Bioact Mater. 2025; 46():331-346.
PMID: 39816475
PMC: 11732853.
DOI: 10.1016/j.bioactmat.2024.12.020.
Visfatin Enhances RANKL-Induced Osteoclastogenesis In Vitro: Synergistic Interactions and Its Role as a Mediator in Osteoclast Differentiation and Activation.
Ok C, Kwon R, Jang H, Bae M, Bae S
Biomolecules. 2025; 14(12.
PMID: 39766208
PMC: 11673010.
DOI: 10.3390/biom14121500.
Enhanced fatty acid oxidation in osteoprogenitor cells provides protection from high-fat diet induced bone dysfunction.
Nandy A, Helderman R, Thapa S, Peck S, Richards A, Jayapalan S
J Bone Miner Res. 2024; 40(2):283-298.
PMID: 39657629
PMC: 11789392.
DOI: 10.1093/jbmr/zjae195.
Selective Pyk2 inhibition enhances bone restoration through SCARA5-mediated bone marrow remodeling in ovariectomized mice.
Liu Y, Nishiura M, Fujii M, Sandhu S, Yawaka Y, Yamazaki Y
Cell Commun Signal. 2024; 22(1):561.
PMID: 39578816
PMC: 11583405.
DOI: 10.1186/s12964-024-01945-8.
Neural Influences on Tumor Progression Within the Central Nervous System.
Lv W, Wang Y
CNS Neurosci Ther. 2024; 30(10):e70097.
PMID: 39469896
PMC: 11519750.
DOI: 10.1111/cns.70097.
's role in RANKL-induced osteoclast differentiation: insights from a bone marrow macrophage model.
Zhang N, Wang L, Ye X
PeerJ. 2024; 12:e18222.
PMID: 39399421
PMC: 11470767.
DOI: 10.7717/peerj.18222.
Air Pollution and Osteoporosis.
Allen O, Knight M, Verbruggen S
Curr Osteoporos Rep. 2024; 22(6):590-598.
PMID: 39302569
PMC: 11499323.
DOI: 10.1007/s11914-024-00889-9.
Saikosaponin A attenuates osteoclastogenesis and bone loss by inducing ferroptosis.
Li T, Liu Y, Feng C, Bai J, Wang Z, Zhang X
Front Mol Biosci. 2024; 11:1390257.
PMID: 39114369
PMC: 11303733.
DOI: 10.3389/fmolb.2024.1390257.
Caspase-8 promotes scramblase-mediated phosphatidylserine exposure and fusion of osteoclast precursors.
Krishnacoumar B, Stenzel M, Garibagaoglu H, Omata Y, Sworn R, Hofmann T
Bone Res. 2024; 12(1):40.
PMID: 38987568
PMC: 11237014.
DOI: 10.1038/s41413-024-00338-4.
Contribution of Osteoblast and Osteoclast Supernatants to Bone Formation: Determination Using a Novel Microfluidic Chip.
Park S, An H, Kim H, Song I, Lee S
Int J Mol Sci. 2024; 25(12).
PMID: 38928310
PMC: 11203825.
DOI: 10.3390/ijms25126605.
Bone-organ axes: bidirectional crosstalk.
Deng A, Wang F, Wang S, Zhang Y, Bai L, Su J
Mil Med Res. 2024; 11(1):37.
PMID: 38867330
PMC: 11167910.
DOI: 10.1186/s40779-024-00540-9.
An adaptive biodegradable zinc alloy with bidirectional regulation of bone homeostasis for treating fractures and aged bone defects.
Xu J, Bao G, Jia B, Wang M, Wen P, Kan T
Bioact Mater. 2024; 38:207-224.
PMID: 38756201
PMC: 11096722.
DOI: 10.1016/j.bioactmat.2024.04.027.
RUFY4 deletion prevents pathological bone loss by blocking endo-lysosomal trafficking of osteoclasts.
Kim M, Park J, Go M, Lee N, Seo J, Lee H
Bone Res. 2024; 12(1):29.
PMID: 38744829
PMC: 11094054.
DOI: 10.1038/s41413-024-00326-8.